牙龈组织人β防御素水平与感染及炎症的关系
研究纳入21例牙周炎患者的48个牙周袋位点,按边缘性、轻度、中重度炎症分级,检测牙龈组织hBD-2和hBD-3水平、龈下菌斑P. gingivalis计数、牙龈蛋白酶及总蛋白酶活性、Th17相关细胞因子浓度。结果发现重度炎症位点P. gingivalis计数、牙龈蛋白酶活性及IL-1β、IL-10、IL-17A、IL-17F、IL-23浓度升高,但hBD-2和hBD-3水平无变化;蛋白酶活性与hBD-2和hBD-3呈负相关。结论提示炎症从边缘性向轻度进展与P. gingivalis计数和牙龈蛋白酶活性升高有关,但与组织hBD水平无关,hBD与总蛋白酶活性负相关提示抗菌肽在进展性炎症中被降解。
要点
- 重度炎症位点P. gingivalis计数、牙龈蛋白酶活性及IL-17相关细胞因子升高,但hBD-2和hBD-3无变化。
- 蛋白酶活性与hBD-2(p=.033)和hBD-3(p=.003)呈负相关,提示抗菌肽可能被降解。
- 炎症从边缘性向轻度进展与P. gingivalis和牙龈蛋白酶升高相关,与hBD水平无关。
核心结论
- 牙龈炎症从边缘性向轻度进展与龈下菌斑P. gingivalis计数和牙龈蛋白酶活性升高相关,但与组织hBD-2和hBD-3水平无关。
- hBD与总蛋白酶活性呈负相关,提示这些抗菌肽在进展性炎症中可能被降解。
研究设计与样本
- 采集21例牙周炎患者的48个牙周袋位点牙龈组织和龈下菌斑样本,按边缘性、轻度、中重度炎症分级。
- hBD水平用免疫检测法测定,P. gingivalis计数用实时聚合酶链反应,蛋白酶活性用荧光底物法,细胞因子浓度用Luminex技术。
- 数据采用Kruskal-Wallis检验、Mann-Whitney U检验和Spearman相关系数进行统计分析。
主要发现
- 重度炎症位点P. gingivalis计数(p=.001)和牙龈蛋白酶活性(p<.001)升高。
- 重度炎症位点IL-1β(p=.012)、IL-10(p=.024)、IL-17A(p=.002)、IL-17F(p=.006)和IL-23(p=.036)浓度升高。
- 重度炎症位点hBD-2和hBD-3水平无变化。
- 蛋白酶活性与hBD-2(p=.033)和hBD-3(p=.003)水平呈负相关。
临床怎么用
- 牙周炎症进展评估可关注P. gingivalis计数和牙龈蛋白酶活性,而非仅依赖hBD水平。
- 总蛋白酶活性升高可能降低hBD-2和hBD-3的抗菌效能,提示蛋白酶抑制或为辅助策略。
局限性
- 样本来自21例牙周炎患者的48个位点,样本量有限。
- 研究为横断面设计,无法确定hBD变化与炎症进展的因果时序。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To profile gingival tissue levels of human beta-defensin (hBD)-2 and hBD-3 in relation to gingival inflammation, Th17-related cytokine concentrations, Porphyromonas gingivalis counts, and gingipain and total protease activities. MATERIALS AND METHODS: Gingival tissue and subgingival plaque samples were collected from 21 periodontitis patients including 48 periodontal pocket sites with marginal, mild, or moderate to severe inflammation. hBD levels were determined by immunodetection, P. gingivalis counts with real-time polymerase chain reaction, protease activities with fluorogenic substrates, and cytokine concentrations with Luminex technique. Data were statistically analysed using Kruskal-Wallis and Mann-Whitney U tests and Spearman correlation coefficients. RESULTS: Subgingival plaque counts of P. gingivalis (p = .001) and gingipain activity (p < .001), as well as interleukin (IL)-1β (p = .012), IL-10 (p = .024), IL-17A (p = .002), IL-17F (p = .006), and IL-23 (p = .036) concentrations were elevated in severely inflamed sites, whereas no change was observed in hBD-2 and hBD-3 levels. Negative correlations were found between protease activity and hBD-2 (p = .033) and hBD-3(p = .003) levels. CONCLUSIONS: Shift in gingival inflammation from marginal to mild stage is related to elevations in subgingival plaque P. gingivalis counts and gingipain activity, but not to tissue hBD levels. Negative correlations between hBDs and total protease activity suggest the degradation of these antimicrobial peptides in progressed inflammation.
引用
- Özdemir M, Caglayan F, Bikker FJ, et al. Gingival tissue human beta-defensin levels in relation to infection and inflammation. J Clin Periodontol. 2020. PMID: 31799742. doi:10.1111/jcpe.13227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。